In vivo effects of apoE and clusterin on amyloid-β metabolism and neuropathology
- 469 Downloads
The ε4 allele of apolipoprotein E APOE is a risk factor for Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA), and the ε2 allele is associated with a decreased risk for AD. There is strong evidence to suggest that a major, if not the main, mechanism underlying the link between apoE and both AD and CAA is related to the ability of apoE to interact with the amyloid-β (Aβ) peptide and influence its clearance, aggregation, and conformation. In addition to a number of in vitro studies supporting this concept, in vivo studies with amyloid precursor protein (APP) transgenic mice indicate that apoE and a related molecule, clusterin (also called apolipoprotein J), have profound effects on the onset of Aβ deposition, as well as the local toxicity associated with Aβ deposits both in the brain parenchyma and in cerebral blood vessels. Taken together, these studies suggest that altering the expression of apoE and clusterin in the brain or the interactions between these molecules and Aβ would alter AD pathogenesis and provide new therapeutic avenues for prevention or treatment of CAA and AD.
Index EntriesAlzheimer’s disease apolipoprotein E clusterin amyloid
Unable to display preview. Download preview PDF.
- DeMattos R. B., Brendza R. P., Heuser J. E., Kierson M., Cirrito J. R., Fryer J. D., et al. (2001) Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem. Int. 39, 415–425.PubMedCrossRefGoogle Scholar
- DeMattos R. B., O’dell M. A., Parsadanian M., Taylor J. W., Harmony J. A. K., Bales K. R., et al. (2002a) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 99, 10843–10848.PubMedCrossRefGoogle Scholar
- DeMattos R. B., Parsadanian M., O’Dell M. A., Taylor J. W., Bales K. R., Paul S. M., et al. (2002b) Apolipoprotein E3 dose dependent modulation of Aβ deposition in a transgenic mouse model of Alzheimer’s disease. Soc. Neurosci. Abstr. 32, 723.Google Scholar
- LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23404–23406.Google Scholar
- Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., et al. (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977–1981.PubMedCrossRefGoogle Scholar
- Sullivan P. M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R. L., et al. (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 17972–17980.PubMedCrossRefGoogle Scholar
- Zlokovic B. V., Martel C. L., Matsubara E., McComb J. G., Zheng G., McCluskey R. T., et al. (1996) Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer’s disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. USA 93, 4229–4234.PubMedCrossRefGoogle Scholar